LGND filings
Corporate insider profile
Andrew Reardon Filing Activity
Latest reported as CLO & Secretary of LIGAND PHARMACEUTICALS INC (LGND).
- Purchase filings
- 0
- Reported companies
- 1
- Net open-market value
- -$2,291,871.00
- Latest transaction
- Jun 1, 2026
Affiliated corporations
Reported company relationships
Transaction history
